GlassScriptPhysician profile
Scott C Robertson
NPI 1356394423
$606,262.70
in general payments reported to CMS, 2019-2025
29 companies · $128K in 2025
The $128K reported for 2025 was more than what 98% of Neurological Surgery providers received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $66K · 2020: $69K · 2021: $73K · 2022: $83K · 2023: $89K · 2024: $98K · 2025: $128K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $284K · Consulting Fee: $13K · Honoraria: $13K · Travel and Lodging: $4,585 · Food and Beverage: $1,208.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $284,202.32 |
| Consulting Fee | $12,665.00 |
| Honoraria | $12,510.00 |
| Travel and Lodging | $4,585.03 |
| Food and Beverage | $1,208.24 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Orthofix Medical, INC. | $252,350.91 | 2023-2025 | Shoreline Asc, Physio-Stim, Shoreline Rt |
| Seaspine Orthopedics Corporation | $217,187.67 | 2019-2022 | |
| Alphatec Spine, INC | $105,331.81 | 2019-2025 | Solus Alif, Other - Miscellaneous, Bridgepoint |
| Pacira Pharmaceuticals Incorporated | $23,622.10 | 2021-2025 | Exparel, Iovera, Zilretta |
| Eminent Spine, LLC | $4,500.00 | 2024 | Eminent Spine 3d Lumbar Interbody Fusion Systems |
| Boston Scientific Corporation | $1,154.16 | 2022-2023 | Wavewriter Alpha Prime 16 |
| Medtronic USA, INC. | $999.53 | 2019 | |
| Nevro Corp. | $165.39 | 2022 | |
| Abbvie INC. | $123.79 | 2023 | Vraylar |
| Medacta USA, INC. | $111.15 | 2025 | Myspine |
| Globus Medical, INC. | $102.50 | 2022 | |
| Abbott Laboratories | $75.40 | 2025 | Infinity, Proclaim |
| Amplify Surgical, INC. | $54.26 | 2021 | |
| Protega Pharmaceutials INC | $53.31 | 2025 | Roxybond |
| Providence Medical Technology, INC. | $50.22 | 2020 |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Baxter Healthcare | $48.19 | 2025 | Floseal |
| Livanova USA, INC. | $43.02 | 2019-2023 | Vns Therapy Sentiva Model 1000 Generator |
| Gt Medical Technologies, INC | $38.97 | 2021 | |
| Medtronic, INC. | $38.83 | 2023 | Mazor X System |
| Stryker Corporation | $35.47 | 2019 | |
| Arbor Pharmaceuticals, INC. | $34.98 | 2019-2020 | |
| Amgen INC. | $24.31 | 2023 | Prolia, Evenity |
| Pfizer INC. | $23.43 | 2019 | |
| Bioventus LLC | $18.57 | 2021 | |
| Supernus Pharmaceuticals, INC. | $17.06 | 2022 | |
| Wright Medical Technology, INC. | $16.50 | 2019 | |
| Genentech USA, INC. | $15.67 | 2020 | |
| Elite Orthopedics, LLC | $14.29 | 2024 | |
| Sanofi Pasteur INC. | $11.21 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Scott Robertson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.